- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Melanoma With KIT Aberration in United Kingdom
Total 636 results
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic MelanomaMetastatic MelanomaUnited States
-
National Cancer Institute (NCI)CompletedMetastatic MelanomaUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterCompletedMetastatic MelanomaUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterTerminatedMetastatic MelanomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbWithdrawn
-
University of Texas Southwestern Medical CenterWithdrawnMelanoma | Metastatic MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)Completed
-
Western Regional Medical CenterTerminated
-
NYU Langone HealthTerminatedMetastatic MelanomaUnited States
-
Gemin XTerminatedMetastatic MelanomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedMetastatic MelanomaUnited States
-
Maxim PharmaceuticalsNational Cancer Institute (NCI)UnknownMetastatic Cancer | Melanoma (Skin)United States, Canada, Germany, United Kingdom
-
Aivita Biomedical, Inc.Recruiting
-
Novartis PharmaceuticalsTerminated
-
OncoImmune, Inc.National Cancer Institute (NCI); Huntsman Cancer InstituteWithdrawnMetastatic MelanomaUnited States
-
Yale UniversityTerminatedMetastatic MelanomaUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); University of Southern California; University... and other collaboratorsCompletedMetastatic MelanomaUnited States
-
Oncolytics BiotechUniversity of TexasCompletedMetastatic MelanomaUnited States
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Unresectable MelanomaUnited States, France
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbCompleted
-
Novartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterBristol-Myers SquibbCompleted
-
University of LouisvilleJames Graham Brown Cancer CenterActive, not recruitingMetastatic MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMetastatic MelanomaUnited States
-
Walter J. StorkusNational Cancer Institute (NCI)Completed
-
University of California, IrvineTerminatedMetastatic MelanomaUnited States
-
John P. FruehaufBayerCompletedMetastatic MelanomaUnited States
-
American Regent, Inc.Completed
-
Western Regional Medical CenterWithdrawnMetastatic MelanomaUnited States
-
John KirkwoodNational Cancer Institute (NCI); National Institutes of Health (NIH)Terminated
-
Beth Israel Deaconess Medical CenterGenzyme, a Sanofi CompanyCompletedMetastatic MelanomaUnited States
-
University of ChicagoCompletedMetastatic MelanomaUnited States
-
Providence Health & ServicesWithdrawn
-
Nektar TherapeuticsImaginAb, Inc.Withdrawn
-
PfizerTerminatedMetastatic Pancreatic Adenocarcinoma | BRAF Mutated MelanomaUnited States, Australia, Belgium, Canada, France, Italy, Spain, United Kingdom
-
California Pacific Medical Center Research InstituteTesaro, Inc.; Vanderbilt-Ingram Cancer Center; Huntsman Cancer InstituteRecruitingMetastatic MelanomaUnited States
-
Saint John's Cancer InstituteTerminatedMetastatic MelanomaUnited States
-
University of IowaNovartis Pharmaceuticals; Holden Comprehensive Cancer CenterTerminatedMetastatic MelanomaUnited States
-
California Pacific Medical Center Research InstitutePfizer; University of California, San FranciscoCompleted
-
Columbia UniversityMerck Sharp & Dohme LLCTerminated
-
California Cancer Assocaties for Research & ExcellenceUnknownMetastatic Melanoma | Malignant Melanoma of Skin Stage IIIUnited States
-
Yousef ZakhariaUniversity of Iowa; ExelixisRecruitingAdvanced Metastatic MelanomaUnited States
-
Northern California Melanoma CenterPfizer; Schering-PloughTerminated
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI)RecruitingMetastatic MelanomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); NovoCure Ltd.RecruitingMetastatic Melanoma | Melanoma of Unknown Primary | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Metastatic Mucosal Melanoma | Metastatic Ocular MelanomaUnited States
-
California Pacific Medical Center Research InstituteM.D. Anderson Cancer CenterRecruitingMetastatic MelanomaUnited States
-
VicalCompletedMetastatic MelanomaUnited States
-
Lynn E. Spitler, MDUniversity of California, San FranciscoCompletedMalignant Melanoma, MetastaticUnited States